Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
about
A Review of HIV Pre-Exposure Prophylaxis: The Female PerspectiveHIV Prevention: Opportunities and Challenges.Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.Genetic Variation of the Kinases that Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells.Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes.Efficacy and Safety of Oral TDF-Based Pre-exposure Prophylaxis for Men Who Have Sex With Men: A Systematic Review and Meta-Analysis
P2860
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phase 2 Study of the Safety an ...... ith Men (HPTN 069/ACTG A5305).
@en
type
label
Phase 2 Study of the Safety an ...... ith Men (HPTN 069/ACTG A5305).
@en
prefLabel
Phase 2 Study of the Safety an ...... ith Men (HPTN 069/ACTG A5305).
@en
P2093
P2860
P50
P356
P1476
Phase 2 Study of the Safety an ...... ith Men (HPTN 069/ACTG A5305).
@en
P2093
Adriana Andrade
Albert Liu
Alex R Rinehart
Alicia M Young
Cheryl Marcus
Craig W Hendrix
Ian McGowan
James F Rooney
Joanne D Stekler
P2860
P304
P356
10.1093/INFDIS/JIW525
P407
P577
2016-11-02T00:00:00Z